- This event has passed.
CDC COCA Call: Recommendations for the Use of Herpes Zoster Vaccines
May 10 @ 2:00 pm - 3:00 pm
Herpes zoster, also known as shingles, is a common viral disease with about one million cases occurring each year in the United States. In October 2017, the Food and Drug Administration (FDA) approved a 2-dose, recombinant zoster vaccine ([RZV], Shingrix), for the prevention of herpes zoster in adults aged ≥50 years. The Centers for Disease Control and Prevention (CDC) recommends Shingrix for use in immunocompetent adults age ≥50 years. During this COCA Call, clinicians will learn about CDC recommendations for herpes zoster vaccines and the clinical guidelines for the new vaccine.
At the time of this webinar, please join the webinar (ID: 101 402 913) at https://zoom.us/j/1014029130. Alternate options include:
- Or iPhone one-tap:
- US: +14086380968,,101402913# or +16468769923,,101402913#
- Or Telephone:
- US: +1 408 638 0968 or +1 646 876 9923 or +1 669 900 6833
The recordings (audio, slides, and transcript) for this call will be posted on the webpage a week after the COCA Call. Free Continuing Education (CE) is available for most COCA Calls. Please see below for instructions on how to receive CE.
To receive continuing education (CE) for WC2922-051018 – (Live) Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Recommendations for the Use of Herpes Zoster Vaccines – May 10, 2018, please visit TCEO and follow these 9 Simple Steps by June 10, 2018.
To receive continuing education (CE) for WD2922-051018 – (Enduring) Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Recommendations for the Use of Herpes Zoster Vaccines – May 10, 2018 (Web on Demand), please visit TCEO and follow these 9 Simple Steps by June 10, 2020.